The Jean Coutu Group recently announced that it is acquiring a 50% stake in Le Groupe Médicus, which specializes in orthotic and prosthetic devices.

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

The Kessler Foundation and the Heldrich Center for Workforce Development last week released a research brief on disability employment titled “Strategies to Support Employer-Driven Initiatives to Recruit and Retain Employees with Disabilities” that explores the growing trend among employers in accommodating workers with disabilities.

Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest lobbying group for the drug industry said Thursday.

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

After ending its five-week fundraising campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases, Safeway announced that its stores raised $10.4 million for the organization.

An investigational schizophrenia drug appears effective in reducing agitation in patients with the disease, according to results of a late-stage clinical trial published in the British Journal of Psychiatry.

The companies working on more than half of the mental illness drugs under development are...

A food and drug retailer and its philanthropic arm raised more than $10 million to...